GRDN
Guardian Pharmacy Services, Inc.
NYSE · Healthcare · Medical - Distribution · US
$40.77
+1.59%Year over year
Reported trailing growth
- Revenue
- +10.3%
- EBITDA
- +377.8%
- EBIT
- +247.3%
- EPS
- +170.0%
- Free cash flow
- +110.4%
- Operating cash flow
- +71.4%
Forward estimates
Based on analyst estimates
- Revenue
- +1.8%
- EBITDA
- +25.7%
- EPS
- +27.9%
Three-year CAGR
- Revenue
- +16.8%
- EBITDA
- +12.3%
- EBIT
- +19.6%
- Net income
- +11.6%
- EPS
- +10.8%
- Free cash flow
- +36.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026